Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 Pacific Biosciences of California, Inc. beats earnings expectations.
PacBio Grants Equity Incentive Award to New Employee
PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted a ...
SoftBank adds to shares in VTEX, YMM, cuts NMRA and exits DASH, among other moves
The Japanese investment holding company SoftBank Group ( OTCPK:SFTBY) purchased two new stakes: 20.45M shares in Pacific Biosciences of California ( PACB ), and 14.66M shares in Recursion ...
Alibaba, Airbnb Lead Friday's Market Cap Stock Movers
Friday's market has seen significant movements in a range of stocks, with some experiencing sharp increases while others face ...
SoftBank reports new stakes in PacBio, Recursion Pharmaceuticals
SoftBank disclosed a 20.45M share position in PacBio (PACB) and 14.67M share position in Recursion Pharmaceuticals (RXRX) in a regulatory ...
PACB Stock Down Following In-Line Q4 Earnings, Revio Shipments Fall
Despite strong Service and other revenues, PacBio reports soft fourth-quarter 2024 results partly due to lower Revio system ...
PacBio should return to growth over time, says Canaccord
Canaccord reiterates a Buy rating on PacBio (PACB) with a $3 price target following the company’s Q4 report. The firm says that although PacBio ...
PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results
PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2024. Fourth quarter results Revenue of ...